Solventum: Q4 EPS Beats, Cash Flow Dips

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory pressures.Diversified healthcare company Solventum (SOLV -0.71%) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped analysts' consensus estimates. Adjusted EPS for the quarter came in at $1.41 against an anticipated $1.31 and revenue of $2.074 billion exceeded the expected $2.050 billion. Despite this, its adjusted free cash flow fell significantly to $92 million from ...